Nyxoah (NYXH : NASDAQ)
Common Stock
$1.55
USD
+0.00 (%)
Last updated: 2026-09-17
Get NYXH alerts:
NYXH
Nyxoah
WealthAwesomePerformance
1 Day
+0.65%
1 Week
+1.97%
1 Month
-3.13%
YTD
-2.52%
Key Statistics
Market Cap
$157.85M
52W High
$6.87
52W Low
$1.26
P/E Ratio
-
50 Day MA
$1.55
200 Day MA
$3.09
Beta
0.96
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/17/2026 | $1.56 | $1.56 | $1.48 | $1.49 | $1.49 | 74,375 |
| 9/16/2026 | $1.56 | $1.58 | $1.53 | $1.55 | $1.55 | 152,148 |
| 9/15/2026 | $1.58 | $1.58 | $1.53 | $1.54 | $1.54 | 64,330 |
| 9/14/2026 | $1.55 | $1.62 | $1.54 | $1.60 | $1.60 | 154,441 |
| 9/11/2026 | $1.54 | $1.57 | $1.51 | $1.54 | $1.54 | 179,477 |
| 9/10/2026 | $1.51 | $1.52 | $1.47 | $1.50 | $1.50 | 185,200 |
| 9/9/2026 | $1.56 | $1.56 | $1.50 | $1.52 | $1.52 | 237,800 |
| 9/8/2026 | $1.63 | $1.64 | $1.54 | $1.56 | $1.56 | 373,700 |
| 9/4/2026 | $1.74 | $1.81 | $1.59 | $1.62 | $1.62 | 1,004,900 |
| 9/3/2026 | $1.82 | $1.83 | $1.65 | $1.76 | $1.76 | 4,585,600 |
Analyst Price Targets
Based on 5 analysts covering NYXH · as of Sep 17, 2026
Wall Street analysts forecast NYXH stock price to rise 177.3% over the next 12 months.
Consensus
Buy4.40 / 5.00
Avg. Target
US$4.30
+177.3% Upside
Current Price
US$1.55
Last close
Analyst Breakdown (5 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NYXH's historical volatility
30-Day Vol
77.3%
Annualized
90-Day Vol
61.3%
Annualized
Trend (90d)
-22.0%
Annualized drift
90d Mean
US$1.38
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$1.45 | US$1.11 – US$1.90 |
| 60 trading days | US$1.41 | US$0.97 – US$2.06 |
| 90 trading days | US$1.38 | US$0.87 – US$2.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Nyxoah
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Financials
- Revenue (TTM)
- $21.66M
- EBITDA
- $-82.74M
- Profit Margin
- 0.00%
- ROE (TTM)
- -122.68%
- EPS (Diluted)
- -2.55
- Book Value
- 0.96
Classification
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Group
- Health Care Equipment & Services
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About NYXH.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| DLXY | Delixy Holdings Limited Ordinary Shares | $2.29 | +451.81% |
| MEDS | DataMEDS AI, Inc. | $6.07 | +274.69% |
| SNYR | Synergy CHC Corp. Common Stock | $0.27 | +234.15% |
| QCLS | Q/C Technologies, Inc. | $0.96 | +118.45% |
| AEHL | Antelope Enterprise Holdings Ltd | $9.22 | +78.68% |
| ZTG | Zenta Group Company Limited | $1.18 | +75.33% |
| PDSB | PDS Biotechnology Corp | $0.99 | +69.25% |
| TPST | Tempest Therapeutics Inc | $1.21 | +60.18% |